To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Points - Regentis Biomaterials Ltd. has announced the pricing of its initial public offering (IPO) of 1,250,000 ordinary shares at $8.00 per share, aiming for gross proceeds of $10 million before expenses [1][3] - The ordinary shares are set to begin trading on the NYSE American under the symbol "RGNT" on December 4, 2025, with the offering expected to close around December 5, 2025 [2] - The company plans to utilize the net proceeds primarily for development activities, including completing its pivotal trial and preparing for PMA submission for its product GerlinC, as well as for corporate purposes such as debt repayment [3] Company Overview - Regentis Biomaterials Ltd. focuses on regenerative medicine, specifically developing innovative tissue repair solutions to enhance patient health and quality of life [6] - The company's lead product, GelrinC, is a cell-free hydrogel designed for treating articular knee cartilage injuries and has received CE mark approval in Europe [6] - Regentis aims to commercialize GelrinC in Europe while also working towards obtaining FDA approval in the United States [6]

Group 1 - The presentation features Graham Parry from Citigroup introducing Sanofi and its CEO, Paul Hudson, at an investment community event in Miami [1] - Investors are particularly interested in Sanofi's plans regarding the Dupixent loss of exclusivity (LOE) expected in 2031 and the company's outlook post-LOE [2]

Market Overview - Market indexes experienced solid gains, with the Dow increasing by 408 points (+0.86%), S&P 500 by 20 points (+0.30%), Nasdaq by 40 points (+0.17%), and Russell 2000 by 47 points (+1.91%) [1] - Weak jobs figures from ADP's November private-sector payrolls report have reinforced expectations for a 25 basis-point rate cut next week, potentially lowering the Fed funds rate to 3.50-3.75% for the first time in over three years [1] Earnings Reports - Salesforce.com (CRM) reported Q3 earnings of $3.25 per share, exceeding expectations of $2.85, with revenues of $10.26 billion, reflecting an 8.6% year-over-year growth [2][3] - Five Below (FIVE) reported Q3 earnings of $0.68 per share, significantly above expectations of $0.22, with revenues of $1.04 billion, surpassing the $970 million consensus, and a 14.3% increase in comparable store sales [4] - Snowflake (SNOW) achieved Q3 earnings of $0.35 per share on revenues of $1.21 billion, beating estimates but saw a stock sell-off of 8.5% in after-hours trading despite raised revenue guidance [5] Upcoming Earnings - Notable companies reporting earnings include Kroger (KR) and Bank of Montreal (BMO) before the market opens, and DocuSign (DOCU) and Ulta Beauty (ULTA) after the close, with varying Zacks Rank ratings [8]

Core Viewpoint - Monument Mining Limited has announced positive initial results from its expansion drilling program at the Selinsing Gold Mine, indicating potential for increased gold resources and an extended mine life [1][2][8]. Drilling Program Overview - The Buffalo Reef/Felda mine expansion drilling program consists of 118 planned drill holes totaling 17,477 meters, with 109 holes for 15,377 meters at Buffalo Reef and 9 holes for 2,100 meters at Selinsing [7][36]. - The first 27 drill holes have been completed, totaling 2,952 meters, with assay results for 16 holes received and 11 pending [3][15]. Significant Assay Results - Notable assay results include: - MBRRC579: 22m @ 0.86g/t Au from 2m, including 1m @ 1.41g/t Au from 2m and 6m @ 1.9g/t Au from 8m [6][33]. - MBRRCDD01: 5m @ 2.01g/t Au & 0.47% Sb from 149m and 1m @ 1.14g/t Au & 0.2% Sb from 160m [34][51]. - MBRDD600: 4m @ 3.42g/t Au & 0.49% Sb from 55m [34][51]. Expansion Drilling Objectives - The objective of the expansion drilling is to increase gold resources and potentially extend the life of the Selinsing Gold Mine [2][9]. - The Buffalo Reef/Felda expansion target area covers 115 acres, aiming to evaluate the potential to extend currently defined mineral resources [2][17]. Budget and Timeline - The company has budgeted USD $2.5 million for the completion of both expansion drilling programs, targeting full completion by the end of June 2026 [8][43]. - The mine expansion drilling is expected to be completed by March 2026, with final assay results anticipated by the end of June 2026 [8][43]. Current Progress and Future Plans - The drilling program has been accelerated with the addition of two diamond drilling rigs to meet the schedule [16][27]. - An updated geological model and resource estimate are expected to be completed by October 2026 [16][43]. Selinsing Mine Expansion Drilling - The Selinsing mine expansion drilling program consists of 9 drill holes for 2,100 meters, with Stage 1 testing high-grade depth extensions and Stage 2 focusing on dip and strike extensions outside the expanded pit shell [36][41][42].

Some investors are hoping for an Intel resurgence, but they could be missing out on Taiwan Semiconductor's established lead.Rumors are circulating that Intel (INTC +0.67%) could manufacture some of Apple's (AAPL 0.71%) low-end M-series chips, potentially stealing business away from Taiwan Semiconductor (TSM +1.11%). That would be a significant development for Intel, as the company attempts to catch up in the semiconductor industry, and could be worth up to $1 billion annually, according to some estimates.In ...

Serve Robotics surged after a report that the Trump administration plans to issue a major executive order on robotics.Shares of Serve Robotics (SERV +18.24%) jumped on Wednesday, finishing the day up 18.2%. The spike came as the S&P 500 gained 0.3% and the Nasdaq Composite rose 0.1%.A report from Politico revealed today that the Trump administration considers the robotics industry a critical part of its push to develop domestic manufacturing.NASDAQ : SERVServe RoboticsToday's Change( 18.24 %) $ 1.82Current ...

There's a robotics gap between China and other countries; current U.S. leadership apparently wants to narrow it.The U.S. federal government appears to be throwing its considerable weight behind the development of robots in the country. News of this gave some real power to stocks in the industry on Wednesday. Richtech Robotics (RR +18.54%) was one such beneficiary; its share price closed the day nearly 19% higher in value. Rise, robotsThat morning, a report in Politico stated that the Trump administration ai ...

Core Viewpoint - DeFi Technologies Inc. is under investigation for potential violations of federal securities laws, which may impact investors who have incurred losses [1] Investigation Details - The investigation is initiated by the Law Offices of Frank R. Cruz on behalf of investors [1] - The investigation follows a press release issued by DeFi on November 6, 2025, indicating possible issues related to compliance with securities regulations [1]

Core Insights - Marvell Technology (MRVL) exceeded Q3 expectations and announced the acquisition of Celestial AI, leading to a significant stock price increase [1][5][11] Financial Performance - Marvell reported record Q3 sales of $2.07 billion, surpassing estimates of $2.06 billion, representing a 37% increase from $1.51 billion in the same quarter last year [5] - Q3 EPS was $0.76, exceeding expectations of $0.75 and showing a 77% increase from $0.43 per share a year ago [5] Future Guidance - Marvell provided optimistic guidance for Q4 sales, projecting around $2.2 billion ±5%, with Zacks estimates at $2.15 billion, indicating 18% growth [6][8] - Full-year revenue growth is expected to exceed 40%, aligning with consensus estimates of $8.12 billion or 41% growth [8] Acquisition Details - The acquisition of Celestial AI is valued at $3.25 billion, potentially rising to $5.5 billion if revenue milestones are met, and is expected to close in the first half of 2026 [3][4] - Celestial AI specializes in advanced photonic interconnect technology, which will enhance Marvell's competitiveness in the AI infrastructure market [4] Valuation Metrics - Marvell's stock is trading at a forward P/E multiple of 32X, which is reasonable compared to the industry average and a discount to its 5-year median of 53X [9]